
Justin C. Dodson
Examiner (ID: 7971, Phone: (571)270-0529 , Office: P/3742 )
| Most Active Art Unit | 3761 |
| Art Unit(s) | 3761, 3742, 2910, 2938 |
| Total Applications | 442 |
| Issued Applications | 170 |
| Pending Applications | 59 |
| Abandoned Applications | 219 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20511303
[patent_doc_number] => 20260035404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-05
[patent_title] => ADVANTAGEOUS MORPHIC FORM OF AT-527 HEMI-SULFATE SALT
[patent_app_type] => utility
[patent_app_number] => 19/350713
[patent_app_country] => US
[patent_app_date] => 2025-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19350713
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/350713 | ADVANTAGEOUS MORPHIC FORM OF AT-527 HEMI-SULFATE SALT | Oct 5, 2025 | Abandoned |
Array
(
[id] => 20349772
[patent_doc_number] => 20250346624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/272275
[patent_app_country] => US
[patent_app_date] => 2025-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19272275
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/272275 | POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF | Jul 16, 2025 | Pending |
Array
(
[id] => 20302402
[patent_doc_number] => 12448380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Positive modulators of the muscarinic acetylcholine receptor M4
[patent_app_type] => utility
[patent_app_number] => 19/002103
[patent_app_country] => US
[patent_app_date] => 2024-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27973
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19002103
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/002103 | Positive modulators of the muscarinic acetylcholine receptor M4 | Dec 25, 2024 | Issued |
Array
(
[id] => 19983979
[patent_doc_number] => 20250122201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
[patent_app_type] => utility
[patent_app_number] => 19/002355
[patent_app_country] => US
[patent_app_date] => 2024-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19002355
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/002355 | POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | Dec 25, 2024 | Abandoned |
Array
(
[id] => 19983976
[patent_doc_number] => 20250122198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
[patent_app_type] => utility
[patent_app_number] => 19/002083
[patent_app_country] => US
[patent_app_date] => 2024-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19002083
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/002083 | POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | Dec 25, 2024 | Abandoned |
Array
(
[id] => 19983978
[patent_doc_number] => 20250122200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
[patent_app_type] => utility
[patent_app_number] => 19/002334
[patent_app_country] => US
[patent_app_date] => 2024-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19002334
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/002334 | POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | Dec 25, 2024 | Abandoned |
Array
(
[id] => 19998378
[patent_doc_number] => 20250136600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
[patent_app_type] => utility
[patent_app_number] => 19/002368
[patent_app_country] => US
[patent_app_date] => 2024-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19002368
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/002368 | Positive modulators of the muscarinic acetylcholine receptor M4 | Dec 25, 2024 | Issued |
| 18/861849 | CHITOSAN OLIGOSACCHARIDE SULFATE AND PREPARATION METHOD THEREOF | Oct 29, 2024 | Pending |
Array
(
[id] => 20547593
[patent_doc_number] => 12558366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-24
[patent_title] => Bacterial DNA gyrase inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/921816
[patent_app_country] => US
[patent_app_date] => 2024-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 130
[patent_no_of_words] => 8928
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18921816
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/921816 | Bacterial DNA gyrase inhibitors and methods of use thereof | Oct 20, 2024 | Issued |
Array
(
[id] => 19743956
[patent_doc_number] => 20250032521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => COGNITION
[patent_app_type] => utility
[patent_app_number] => 18/814957
[patent_app_country] => US
[patent_app_date] => 2024-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18814957
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/814957 | Cognition | Aug 25, 2024 | Issued |
Array
(
[id] => 19969705
[patent_doc_number] => 12338297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Method for obtaining sulfated nanoparticles of cellulose and mannan from endosperms
[patent_app_type] => utility
[patent_app_number] => 18/769736
[patent_app_country] => US
[patent_app_date] => 2024-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 0
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18769736
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/769736 | Method for obtaining sulfated nanoparticles of cellulose and mannan from endosperms | Jul 10, 2024 | Issued |
Array
(
[id] => 19692775
[patent_doc_number] => 20250011320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
[patent_app_type] => utility
[patent_app_number] => 18/750829
[patent_app_country] => US
[patent_app_date] => 2024-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18750829
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/750829 | Positive modulators of the muscarinic acetylcholine receptor M4 | Jun 20, 2024 | Issued |
Array
(
[id] => 19692812
[patent_doc_number] => 20250011357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR PURIFICATION OF OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 18/742011
[patent_app_country] => US
[patent_app_date] => 2024-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18742011
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/742011 | HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR PURIFICATION OF OLIGONUCLEOTIDES | Jun 12, 2024 | Pending |
Array
(
[id] => 19431057
[patent_doc_number] => 20240299555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => Drug Conjugates of Sugar Derivatives and Uses Thereof as Senolytic Agents
[patent_app_type] => utility
[patent_app_number] => 18/655834
[patent_app_country] => US
[patent_app_date] => 2024-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 311
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18655834
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/655834 | Drug Conjugates of Sugar Derivatives and Uses Thereof as Senolytic Agents | May 5, 2024 | Pending |
Array
(
[id] => 19432596
[patent_doc_number] => 20240301094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => METHODS FOR EXTRACTING XYLOSE LIQUID AND CELLULOSE WITH HIGH PURITY FROM CORN STRAW
[patent_app_type] => utility
[patent_app_number] => 18/651620
[patent_app_country] => US
[patent_app_date] => 2024-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 308
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18651620
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/651620 | Methods for extracting xylose liquid and cellulose with high purity from corn straw | Apr 29, 2024 | Issued |
Array
(
[id] => 19666156
[patent_doc_number] => 12178876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Conjugates comprising cleavable linkers
[patent_app_type] => utility
[patent_app_number] => 18/630197
[patent_app_country] => US
[patent_app_date] => 2024-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 19678
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18630197
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/630197 | Conjugates comprising cleavable linkers | Apr 8, 2024 | Issued |
Array
(
[id] => 19379286
[patent_doc_number] => 20240269156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => DISULFIDE CONTAINING THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 18/543979
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18543979
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/543979 | DISULFIDE CONTAINING THERAPEUTICS | Dec 17, 2023 | Pending |
Array
(
[id] => 19279939
[patent_doc_number] => 20240216412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => OXIDIZED NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR TREATMENT FOR HEART FAILURE ALLEVIATION INDEPENDENT OF MITOCHONDRIAL PROTEIN DEACETYLATION
[patent_app_type] => utility
[patent_app_number] => 18/517421
[patent_app_country] => US
[patent_app_date] => 2023-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18517421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/517421 | OXIDIZED NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR TREATMENT FOR HEART FAILURE ALLEVIATION INDEPENDENT OF MITOCHONDRIAL PROTEIN DEACETYLATION | Nov 21, 2023 | Pending |
Array
(
[id] => 18787302
[patent_doc_number] => 20230375576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => METHODS FOR THE TREATMENT OF FAMILIAL HETEROZYGOUS AND HOMOZYGOUS HYPERCHOLESTEROLEMIA WITH CYCLODEXTRINS
[patent_app_type] => utility
[patent_app_number] => 18/365835
[patent_app_country] => US
[patent_app_date] => 2023-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18365835
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/365835 | METHODS FOR THE TREATMENT OF FAMILIAL HETEROZYGOUS AND HOMOZYGOUS HYPERCHOLESTEROLEMIA WITH CYCLODEXTRINS | Aug 3, 2023 | Pending |
Array
(
[id] => 19140440
[patent_doc_number] => 20240139223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => SOY ISOFLAVONES FOR ASTHMA PREVENTION
[patent_app_type] => utility
[patent_app_number] => 18/349517
[patent_app_country] => US
[patent_app_date] => 2023-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18349517
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/349517 | SOY ISOFLAVONES FOR ASTHMA PREVENTION | Jul 9, 2023 | Pending |